Results 221 to 230 of about 19,226,899 (298)

Bulevirtide approved by FDA for chronic hepatitis D

The Lancet Microbe
openaire   +2 more sources

High prevalence of autoantibodies neutralizing type I IFNs in Japanese patients with hepatitis C. [PDF]

J Hum Immun
Taniguchi M, Tao C, Asano T, Tsumura M, Ko K, Kumada H, Utsumi T, Noma K, Sakura F, Ashihara K, Tamaura M, Mizoguchi Y, Ohara O, Bogunovic D, Bastard P, Casanova JL, Tanaka J, Tsuge M, Chayama K, Oka S, Okada S.   +20 more
europepmc   +1 more source

Serological Profile of Hepatitis B, C, and D and Factors Associated With Hepatitis B Exposure and Vaccination Among Hemodialysis Patients in Northeastern Brazil. [PDF]

Int J Nephrol
da Silva LL, Mota JC, Dos Santos AC, da Costa VD, do Nascimento GP, Marques JT, Miguel JC, Liborio AB, Lima DM, Colares JKB, de Paula VS, Villar LM.   +11 more
europepmc   +1 more source

Hepatitis B and D burden in Uzbekistan: comprehensive analysis of seroprevalence and risk correlates from a countrywide study. [PDF]

Infect Dis Poverty
Musabaev EI, Khodjaeva ME, Khikmatullaeva AS, Ibadullaeva NS, Shodieva FSK, Khudaykulova GK, Tadjieva NU, Amonov SB, Mirzaev UK.   +8 more
europepmc   +1 more source

Occult Hepatic Pathology in Medicolegal Autopsies: A Single-Center Histopathological Study From Jharkhand, India. [PDF]

Cureus
Biswal SDR, Paswan MK, Jamaiyar A.
europepmc   +1 more source

Quantitative HBsAg as a biomarker for disease staging in untreated chronic hepatitis B patients: a cross-sectional study. [PDF]

Front Med (Lausanne)
Mrabet S, Handous I, Trabelsi O, Maatouk Y, Harbi R, Akkari I, Hannachi N, Ben Jazia E.   +7 more
europepmc   +1 more source

Development and internal validation of a CatBoost-SHAP-guided nomogram for significant liver fibrosis in children with chronic hepatitis B. [PDF]

Front Med (Lausanne)
Zhang Y, Wu T, Chang Y, Peng X, Zhu K, Liu Y, Shang T, Qin T, Zhu J, Tian J, Zhao R, Xu H.   +11 more
europepmc   +1 more source

Anti-Viral Treatment Eligibility and Treatment Uptake Among People With Chronic Hepatitis B in Australia: The REACH-B Study. [PDF]

J Viral Hepat
Hajarizadeh B, Nelson R, George J, Hanson J, Davies J, Martinello M, Brown T, Wong I, Hasan T, Mascarenhas L, O'Beirne J, Wade A, Capati M, Trotter G, Thomas S, Nash L, Cowie B, Allard N, Tu T, Tran L, Howard S, Monaghan R, Carter J, Tu E, Erratt A, Carson J, Dore GJ, Matthews GV, REACH‐B Study Group.   +28 more
europepmc   +1 more source